BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26894030)

  • 1. Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease.
    Larson DS; Coyne DW
    Kidney Res Clin Pract; 2013 Mar; 32(1):11-5. PubMed ID: 26894030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid anemia.
    Masson C
    Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
    Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
    Coyne DW
    Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
    Ueda N; Takasawa K
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin for clinicians.
    Young B; Zaritsky J
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin.
    Goyal H; Mohanty S; Sharma M; Rani A
    Indian J Nephrol; 2017; 27(1):44-50. PubMed ID: 28182038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hepcidin and anemia in early chronic kidney disease.
    Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
    Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin and Anemia: A Tight Relationship.
    Pagani A; Nai A; Silvestri L; Camaschella C
    Front Physiol; 2019; 10():1294. PubMed ID: 31649559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited iron overload disorders.
    Piperno A; Pelucchi S; Mariani R
    Transl Gastroenterol Hepatol; 2020; 5():25. PubMed ID: 32258529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin is a potential regulator of iron status in chronic kidney disease.
    Tsuchiya K; Nitta K
    Ther Apher Dial; 2013 Feb; 17(1):1-8. PubMed ID: 23379486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron metabolism and management: focus on chronic kidney disease.
    Agarwal AK
    Kidney Int Suppl (2011); 2021 Apr; 11(1):46-58. PubMed ID: 33777495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin: another culprit for complications in patients with chronic kidney disease?
    Nakanishi T; Hasuike Y; Otaki Y; Kida A; Nonoguchi H; Kuragano T
    Nephrol Dial Transplant; 2011 Oct; 26(10):3092-100. PubMed ID: 21785039
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.